Summary: In a single-blind trial in type 2 diabetes, a personalised post-dinner exercise programme based on the submaximal Chester Step Test reduced glycaemic variability under free-living conditions compared with no exercise, though some variability measures did not reach significance.
PICO Summary
| Element | Detail |
|---|---|
| Population | 38 outpatients with type 2 diabetes; single-centre, single-blind RCT, China. |
| Intervention | Personalised exercise prescribed from Chester Step Test VO2 max at 50–75% intensity, 30–60 minutes starting 45 minutes after dinner (n=19). |
| Comparison | Usual routine without vigorous activity (n=19); glucose tracked by CGM. |
| Outcome | On exercise days, the exercise group had a higher postprandial nadir glucose (4.5 vs 5.4 mmol/L; p=0.016), lower glucose standard deviation (1.5 vs 2.0; p=0.027), and lower mean amplitude of glycaemic excursions (3.6 vs 5.5; p=0.0094). Some metrics, including CONGA and low-blood-glucose index, did not differ significantly. |
Chester Step Test-tailored exercise in type 2 diabetes
Single-blind RCT · type 2 diabetes · CGM, on exercise days
CST-personalised post-dinner exercise lowered glucose SD and MAGE and raised the postprandial nadir on exercise days. Benefits were selective and short-term; no hard outcomes were tested.
Expert Commentary
This is a practical study tackling a real translation problem, that personalised exercise prescriptions usually require laboratory cardiopulmonary testing which most clinics cannot offer, whereas the Chester Step Test is a simple, cheap, submaximal field test that could bring individualised dosing within reach. The result is coherent and the use of CGM under free-living conditions adds ecological validity, with reduced glycaemic variability and a higher post-meal nadir suggesting steadier glucose without provoking lows. I would keep the findings in proportion. The sample is small at 38, the trial is single-centre and single-blind, the benefits were demonstrated on exercise days rather than as a sustained change in overall control, and several variability indices did not reach significance, so the effect is real but selective. Whether this translates into HbA1c improvement or complication reduction over time was not tested. Can I use this with my patients? Yes, pragmatically. It supports using a simple step test to tailor exercise intensity rather than giving generic advice, and timing aerobic activity after the evening meal to blunt post-dinner excursions, while I frame the evidence as encouraging short-term physiology that still needs longer trials for hard outcomes.
References
Wang C, Yang H, Zhou H, et al. Clinical application of Chester Step Test in developing personalized exercise prescription in patients with type 2 diabetes: a single-blind, randomized controlled trial. Medicine (Baltimore). 2025;104(44):e45615. doi:10.1097/MD.0000000000045615